SynthesisMedical oncology (Northwood, London, England)2015

Prognostic factors for survival with bevacizumab-based therapy in colorectal cancer patients: a systematic review and pooled analysis of 11,585 patients.

Fausto Petrelli et al.PubMed ↗Publisher ↗

No numbers read from the abstract.